Control of breathing and measurement of disease severity in premature infants with chronic lung disease
- Conditions
- Bronchopulmonary dysplasiaPrematurityRespiratory - Other respiratory disorders / diseasesReproductive Health and Childbirth - Complications of newborn
- Registration Number
- ACTRN12613000124730
- Lead Sponsor
- The Ritchie Centre, Monash University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Preterm infants < 29 weeks gestation.
1. Healthy preterm infant (<29 weeks) without BPD
Infants with BPD defined as need for oxygen or respiratory support at 36 weeks completed postmenstrual age (PMA).
Infants will be further subdivided into
2. Mild BPD (no need for oxygen or respiratory support at 36 weeks PMA but need for either at 28 days of age).
3. Moderate BPD - need for supplemental oxygen (<30%) at 36 weeks PMA butself-ventilating
4. Severe BPD - need for supplemental oxygen (>30%) at 36 weeks PMA or needing respiratory support.
Infants in Group 1, the healthy preterm infant will be the control group while infants in Groups 2 to 4 with mild/moderate/severe BPD will be in the intervention group
Infants with congenital heart disease
Infants with major congenital anomalies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method